共 60 条
- [1] Vernon G(2011)Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol. Ther. 34 274-285
- [2] Baranova A(2018)The epidemiology of nonalcoholic steatohepatitis Clin. Liver Dis. (Hoboken) 11 92-94
- [3] Younossi ZM(2010)Obese boys at increased risk for nonalcoholic liver disease: Evaluation of 16,390 overweight or obese children and adolescents Int. J. Obes. (Lond.) 34 1468-1474
- [4] Younossi ZM(2018)Nonalcoholic fatty liver disease in children Semin. Liver Dis. 38 1-13
- [5] Wiegand S(2019)NAFLD in children: New genes, new diagnostic modalities and new drugs Nat. Rev. Gastroenterol. Hepatol. 16 517-530
- [6] Mann JP(2014)Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology 59 2188-2195
- [7] Valenti L(2013)Evolving aspects of liver transplantation for nonalcoholic steatohepatitis Curr. Opin. Organ Transplant. 18 251-258
- [8] Scorletti E(2012)Nonalcoholic fatty liver disease: Pathologic patterns and biopsy evaluation in clinical research Semin. Liver Dis. 32 3-13
- [9] Byrne CD(2015)Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology 61 1547-1554
- [10] Nobili V(2019)The differential roles of T cells in non-alcoholic fatty liver disease and obesity Front. Immunol. 10 82-1846